Award

NHS Genomic Medicine Service - Most Suitable Provider Process

NHS ENGLAND

This public procurement record has 2 releases in its history.

Award

23 Oct 2025 at 16:00

Planning

24 Jul 2025 at 16:52

Summary of the contracting process

The NHS Genomic Medicine Service (NHS GMS) tender, managed by NHS England, is a significant procurement process aiming to enhance health services across various regions in the United Kingdom. With an estimated total contract value of £5,175,000,000, the services are anticipated to commence on 1st April 2026 and could extend until 31st March 3036. The procurement is segmented into seven distinct Lots, targeting geographic areas like North-West, North-East and Yorkshire, Central and South, with NHS organisations positioned as potential providers. This notice reflects the intention to award under the Provider Selection Regime, highlighting key dates such as the standstill period resulting from the publication on 23rd October 2025 and a deadline for representations by 4th November 2025. The procurement is conducted through a limited procedure, bypassing prior competition calls.

This tender presents substantial opportunities for existing NHS organisations equipped to integrate genomic medicine service functions. It is designed for entities that can demonstrate advanced capabilities in genomic testing, clinical pathways for cancer and rare diseases, and integration of data infrastructure. By enabling expansion in genomic innovation and service delivery, the tender is particularly suited for large-scale NHS suppliers ready to collaborate and leverage existing clinical governance structures. Companies with a focus on integrating new genomic technologies and improving healthcare equity will find immense potential for growth and service improvement in partnership with NHS England through this procurement endeavour.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

NHS Genomic Medicine Service - Most Suitable Provider Process

Notice Description

This is a notice of intention to make an award in respect of the NHS Genomic Medicine Service pursuant to the Most Suitable Provider (MSP) Process for the NHS Genomic Medicine Service (NHS GMS). For the avoidance of doubt, this is an intention to award notice. A notice of the confirmation of the award of each contract will be issued once they are signed.<br/><br/>Pursuant to the NHS GMS contracts, provider are to provide the following functions: <br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disease;<br/>* Clinical function: population health;<br/>* Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>* Transformation and Service Improvement;<br/>* People - workforce, education and training; and<br/>* Data and digital

Lot Information

Lot 1 - NHS North-West GMS

Pursuant to the NHS GMS contracts, providers are to provide the following functions:
* Organisational leadership, governance and partnership arrangements;
* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);
* Laboratory operating model;
* Clinical function: cancer genomics;
* Clinical function: rare disease;
* Clinical function: population health;
* Promotion of and supporting and leading where relevant science, research and / or innovation;
* Transformation and Service Improvement;
* People - workforce, education and training; and
* Data and digital
The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.
The approximate lifetime value of the contract for all Lots is PS5,175,000,000.
The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).
Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).

Options: Options to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period.

Lot 2 - NHS North-East and Yorkshire GMS

Pursuant to the NHS GMS contracts, providers are to provide the following functions:
* Organisational leadership, governance and partnership arrangements;
* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);
* Laboratory operating model;
* Clinical function: cancer genomics;
* Clinical function: rare disease;
* Clinical function: population health;
* Promotion of and supporting and leading where relevant science, research and / or innovation;
* Transformation and Service Improvement;
* People - workforce, education and training; and
* Data and digital
The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.
The approximate lifetime value of the contract for all Lots is PS5,175,000,000.
The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).
Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).

Options: Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period

Lot 3 - NHS Central and South GMS

Pursuant to the NHS GMS contracts, providers are to provide the following functions:
* Organisational leadership, governance and partnership arrangements;
* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);
* Laboratory operating model;
* Clinical function: cancer genomics;
* Clinical function: rare disease;
* Clinical function: population health;
* Promotion of and supporting and leading where relevant science, research and / or innovation;
* Transformation and Service Improvement;
* People - workforce, education and training; and
* Data and digital
The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.
The approximate lifetime value of the contract for all Lots is PS5,175,000,000.
The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).
Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).

Options: Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period

Lot 4 - NHS East GMS

Pursuant to the NHS GMS contracts, providers are to provide the following functions:
* Organisational leadership, governance and partnership arrangements;
* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);
* Laboratory operating model;
* Clinical function: cancer genomics;
* Clinical function: rare disease;
* Clinical function: population health;
* Promotion of and supporting and leading where relevant science, research and / or innovation;
* Transformation and Service Improvement;
* People - workforce, education and training; and
* Data and digital
The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.
The approximate lifetime value of the contract for all Lots is PS5,175,000,000.
The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).
Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).

Options: Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period

Lot 5 - NHS South-West GMS

Pursuant to the NHS GMS contracts, providers are to provide the following functions:
* Organisational leadership, governance and partnership arrangements;
* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);
* Laboratory operating model;
* Clinical function: cancer genomics;
* Clinical function: rare disease;
* Clinical function: population health;
* Promotion of and supporting and leading where relevant science, research and / or innovation;
* Transformation and Service Improvement;
* People - workforce, education and training; and
* Data and digital
The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.
The approximate lifetime value of the contract for all Lots is PS5,175,000,000.
The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).
Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).

Options: Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period

Lot 6 - NHS North Thames GMS

Pursuant to the NHS GMS contracts, providers are to provide the following functions:
* Organisational leadership, governance and partnership arrangements;
* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);
* Laboratory operating model;
* Clinical function: cancer genomics;
* Clinical function: rare disease;
* Clinical function: population health;
* Promotion of and supporting and leading where relevant science, research and / or innovation;
* Transformation and Service Improvement;
* People - workforce, education and training; and
* Data and digital
The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.
The approximate lifetime value of the contract for all Lots is PS5,175,000,000.
The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).
Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).

Options: Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period

Lot 7 - NHS South-East GMS

Pursuant to the NHS GMS contracts, providers are to provide the following functions:
* Organisational leadership, governance and partnership arrangements;
* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);
* Laboratory operating model;
* Clinical function: cancer genomics;
* Clinical function: rare disease;
* Clinical function: population health;
* Promotion of and supporting and leading where relevant science, research and / or innovation;
* Transformation and Service Improvement;
* People - workforce, education and training; and
* Data and digital
The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.
The approximate lifetime value of the contract for all Lots is PS5,175,000,000.
The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).
Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).

Options: Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period

Procurement Information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by Tuesday 4th November 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0565e9
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/067976-2025
Current Stage
Award
All Stages
Planning, Award

Procurement Classification

Notice Type
Planning Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services


CPV Codes

85100000 - Health services

Notice Value(s)

Tender Value
£3,850,000,000 £1B-£10B
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£5,175,000,000 £1B-£10B

Notice Dates

Publication Date
23 Oct 20254 months ago
Submission Deadline
Not specified
Future Notice Date
17 Sep 2025Expired
Award Date
20 Oct 20254 months ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS ENGLAND
Contact Name
Anna Salt
Contact Email
anna.salt@nhs.net
Contact Phone
Not specified

Buyer Location

Locality
LEEDS
Postcode
LS1 4AP
Post Town
Leeds
Country
England

Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLI London, TLJ South East (England), TLK South West (England)

Local Authority
Leeds
Electoral Ward
Hunslet & Riverside
Westminster Constituency
Leeds South

Supplier Information

Number of Suppliers
7
Supplier Names

BIRMINGHAM WOMEN’S AND CHILDREN’S NHS FOUNDATION TRUST

CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST

GREAT ORMOND STREET HOSPITAL FOR CHILDREN NHS FOUNDATION TRUST

GUY'S AND ST THOMAS' NHS FOUNDATION TRUST

MANCHESTER UNIVERSITY NHS FOUNDATION TRUST

NORTH BRISTOL NHS TRUST

THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-0565e9-2025-10-23T17:00:36+01:00",
    "date": "2025-10-23T17:00:36+01:00",
    "ocid": "ocds-h6vhtk-0565e9",
    "description": "This is a Provider Selection Regime (PSR) intention to award notice. This intention to award notice is subject to Regulation 10(7) of the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by midnight on Tuesday 4th November 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.<br/>Written representations should be sent to england.genomics@nhs.net, ensuring the following details are referenced:<br/>Project reference: C368833<br/>Project title: NHS Genomic Medicine Service - Most Suitable Provider process<br/>This decision has been made as per NHS England governance processes, by the Commercial Executive Group on 14th October 2025 and the National Commissioning Group on 21st October 2025. No conflicts of Interest were identified amongst decision-makers.<br/>Each of the 5 key criteria were balanced with equal priority and considered on this basis and consideration was given to the basic selection criteria. Following provider assessments, it was agreed that the providers are the only providers capable of meeting the service specifications and requirements of the NHS GMS in full.<br/><br/>Additional CPV codes include:<br/>85145000-7 (Services provided by medical laboratories),<br/>85148000-8 (Medical analysis services)<br/>85111810-1 (Blood analysis services)<br/>85121200-5 (Medical specialist services)<br/>85140000-2 (Miscellaneous health services)",
    "initiationType": "tender",
    "tender": {
        "id": "C368833",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "NHS Genomic Medicine Service - Most Suitable Provider Process",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "85100000",
            "description": "Health services"
        },
        "mainProcurementCategory": "services",
        "description": "This is a notice of intention to make an award in respect of the NHS Genomic Medicine Service pursuant to the Most Suitable Provider (MSP) Process for the NHS Genomic Medicine Service (NHS GMS). For the avoidance of doubt, this is an intention to award notice. A notice of the confirmation of the award of each contract will be issued once they are signed.<br/><br/>Pursuant to the NHS GMS contracts, provider are to provide the following functions: <br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disease;<br/>* Clinical function: population health;<br/>* Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>* Transformation and Service Improvement;<br/>* People - workforce, education and training; and<br/>* Data and digital",
        "value": {
            "amount": 3850000000,
            "currency": "GBP"
        },
        "lots": [
            {
                "id": "1",
                "title": "Lot 1 - NHS North-West GMS",
                "description": "Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disease;<br/>* Clinical function: population health;<br/>* Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>* Transformation and Service Improvement;<br/>* People - workforce, education and training; and<br/>* Data and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is PS5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).",
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Most suitable provider process with regard to the key Criteria",
                            "type": "cost",
                            "description": "100"
                        }
                    ]
                },
                "hasOptions": true,
                "options": {
                    "description": "Options to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period."
                }
            },
            {
                "id": "2",
                "title": "Lot 2 - NHS North-East and Yorkshire GMS",
                "description": "Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disease;<br/>* Clinical function: population health;<br/>* Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>* Transformation and Service Improvement;<br/>* People - workforce, education and training; and<br/>* Data and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is PS5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).",
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Most suitable provider process with regard to the key Criteria",
                            "type": "cost",
                            "description": "100"
                        }
                    ]
                },
                "hasOptions": true,
                "options": {
                    "description": "Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period"
                }
            },
            {
                "id": "3",
                "title": "Lot 3 - NHS Central and South GMS",
                "description": "Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disease;<br/>* Clinical function: population health;<br/>* Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>* Transformation and Service Improvement;<br/>* People - workforce, education and training; and<br/>* Data and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is PS5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).",
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Most suitable provider process with regard to the key Criteria",
                            "type": "cost",
                            "description": "100"
                        }
                    ]
                },
                "hasOptions": true,
                "options": {
                    "description": "Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period"
                }
            },
            {
                "id": "4",
                "title": "Lot 4 - NHS East GMS",
                "description": "Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disease;<br/>* Clinical function: population health;<br/>* Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>* Transformation and Service Improvement;<br/>* People - workforce, education and training; and<br/>* Data and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is PS5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).",
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Most suitable provider process with regard to the key Criteria",
                            "type": "cost",
                            "description": "100"
                        }
                    ]
                },
                "hasOptions": true,
                "options": {
                    "description": "Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period"
                }
            },
            {
                "id": "5",
                "title": "Lot 5 - NHS South-West GMS",
                "description": "Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disease;<br/>* Clinical function: population health;<br/>* Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>* Transformation and Service Improvement;<br/>* People - workforce, education and training; and<br/>* Data and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is PS5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).",
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Most suitable provider process with regard to the key Criteria",
                            "type": "cost",
                            "description": "100"
                        }
                    ]
                },
                "hasOptions": true,
                "options": {
                    "description": "Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period"
                }
            },
            {
                "id": "6",
                "title": "Lot 6 - NHS North Thames GMS",
                "description": "Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disease;<br/>* Clinical function: population health;<br/>* Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>* Transformation and Service Improvement;<br/>* People - workforce, education and training; and<br/>* Data and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is PS5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).",
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Most suitable provider process with regard to the key Criteria",
                            "type": "cost",
                            "description": "100"
                        }
                    ]
                },
                "hasOptions": true,
                "options": {
                    "description": "Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period"
                }
            },
            {
                "id": "7",
                "title": "Lot 7 - NHS South-East GMS",
                "description": "Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disease;<br/>* Clinical function: population health;<br/>* Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>* Transformation and Service Improvement;<br/>* People - workforce, education and training; and<br/>* Data and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is PS5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).",
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Most suitable provider process with regard to the key Criteria",
                            "type": "cost",
                            "description": "100"
                        }
                    ]
                },
                "hasOptions": true,
                "options": {
                    "description": "Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period"
                }
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "85100000",
                        "description": "Health services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKD"
                    },
                    {
                        "region": "UKD"
                    }
                ],
                "relatedLot": "1"
            },
            {
                "id": "2",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "85100000",
                        "description": "Health services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKC"
                    },
                    {
                        "region": "UKC"
                    }
                ],
                "relatedLot": "2"
            },
            {
                "id": "3",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "85100000",
                        "description": "Health services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKF"
                    },
                    {
                        "region": "UKG"
                    }
                ],
                "relatedLot": "3"
            },
            {
                "id": "4",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "85100000",
                        "description": "Health services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKH"
                    },
                    {
                        "region": "UKH"
                    }
                ],
                "relatedLot": "4"
            },
            {
                "id": "5",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "85100000",
                        "description": "Health services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKK"
                    },
                    {
                        "region": "UKK"
                    }
                ],
                "relatedLot": "5"
            },
            {
                "id": "6",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "85100000",
                        "description": "Health services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKI"
                    },
                    {
                        "region": "UKI"
                    }
                ],
                "relatedLot": "6"
            },
            {
                "id": "7",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "85100000",
                        "description": "Health services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKJ"
                    },
                    {
                        "region": "UKJ"
                    }
                ],
                "relatedLot": "7"
            }
        ],
        "communication": {
            "futureNoticeDate": "2025-09-18T00:00:00+01:00",
            "atypicalToolUrl": "https://health-family.force.com/s/Welcome"
        },
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "procurementMethodRationaleClassifications": [
            {
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "id": "D_OUTSIDE_SCOPE",
                "description": "The procurement falls outside the scope of application of the directive"
            }
        ],
        "procurementMethodRationale": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by Tuesday 4th November 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR."
    },
    "parties": [
        {
            "id": "GB-FTS-118033",
            "name": "NHS England",
            "identifier": {
                "legalName": "NHS England"
            },
            "address": {
                "streetAddress": "7&8 Wellington Place",
                "locality": "Leeds",
                "region": "UKE",
                "postalCode": "LS1 4AP",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "anna.salt@nhs.net",
                "name": "Anna Salt"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.england.nhs.uk//",
                "buyerProfile": "https://www.england.nhs.uk//",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-18796",
            "name": "Manchester University NHS Foundation Trust",
            "identifier": {
                "legalName": "Manchester University NHS Foundation Trust"
            },
            "address": {
                "locality": "Manchester",
                "region": "UKD3",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-78899",
            "name": "The Newcastle upon Tyne Hospitals NHS Foundation Trust",
            "identifier": {
                "legalName": "The Newcastle upon Tyne Hospitals NHS Foundation Trust"
            },
            "address": {
                "locality": "Newcastle",
                "region": "UKC2",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-1009",
            "name": "Birmingham Women's and Children's NHS Foundation Trust",
            "identifier": {
                "legalName": "Birmingham Women's and Children's NHS Foundation Trust"
            },
            "address": {
                "locality": "Birmingham",
                "region": "UKG3",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-6625",
            "name": "Cambridge University Hospitals NHS Foundation Trust",
            "identifier": {
                "legalName": "Cambridge University Hospitals NHS Foundation Trust"
            },
            "address": {
                "locality": "Cambridge",
                "region": "UKH1",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-12898",
            "name": "North Bristol NHS Trust",
            "identifier": {
                "legalName": "North Bristol NHS Trust"
            },
            "address": {
                "locality": "Bristol",
                "region": "UKK1",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-95413",
            "name": "Great Ormond Street Hospital for Children NHS Foundation Trust",
            "identifier": {
                "legalName": "Great Ormond Street Hospital for Children NHS Foundation Trust"
            },
            "address": {
                "locality": "London",
                "region": "UKI3",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-21063",
            "name": "Guy's and St Thomas' NHS Foundation Trust",
            "identifier": {
                "legalName": "Guy's and St Thomas' NHS Foundation Trust"
            },
            "address": {
                "locality": "London",
                "region": "UKI3",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-141301",
            "name": "NHS Arden and Greater East Midlands Commissioning Support Unit",
            "identifier": {
                "legalName": "NHS Arden and Greater East Midlands Commissioning Support Unit"
            },
            "address": {
                "streetAddress": "Cardinal Square, 10 Nottingham Road",
                "locality": "Derby",
                "postalCode": "DE1 3QT",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ],
            "details": {
                "url": "https://www.ardengemcsu.nhs.uk/"
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-118033",
        "name": "NHS England"
    },
    "language": "en",
    "awards": [
        {
            "id": "067976-2025-1",
            "relatedLots": [
                "1"
            ],
            "title": "Lot 1 - NHS North-West GMS",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-18796",
                    "name": "Manchester University NHS Foundation Trust"
                }
            ]
        },
        {
            "id": "067976-2025-2",
            "relatedLots": [
                "2"
            ],
            "title": "Lot 2 - NHS North-East and Yorkshire GMS",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-78899",
                    "name": "The Newcastle upon Tyne Hospitals NHS Foundation Trust"
                }
            ]
        },
        {
            "id": "067976-2025-3",
            "relatedLots": [
                "3"
            ],
            "title": "Lot 3 NHS Central and South GMS",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-1009",
                    "name": "Birmingham Women's and Children's NHS Foundation Trust"
                }
            ]
        },
        {
            "id": "067976-2025-4",
            "relatedLots": [
                "4"
            ],
            "title": "Lot 4 NHS East GMS",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-6625",
                    "name": "Cambridge University Hospitals NHS Foundation Trust"
                }
            ]
        },
        {
            "id": "067976-2025-5",
            "relatedLots": [
                "5"
            ],
            "title": "Lot 5 NHS South-West GMS",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-12898",
                    "name": "North Bristol NHS Trust"
                }
            ]
        },
        {
            "id": "067976-2025-6",
            "relatedLots": [
                "6"
            ],
            "title": "Lot 6 NHS North Thames GMS",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-95413",
                    "name": "Great Ormond Street Hospital for Children NHS Foundation Trust"
                }
            ]
        },
        {
            "id": "067976-2025-7",
            "relatedLots": [
                "7"
            ],
            "title": "Lot 7 NHS South-East GMS",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-21063",
                    "name": "Guy's and St Thomas' NHS Foundation Trust"
                }
            ]
        }
    ],
    "contracts": [
        {
            "id": "067976-2025-1",
            "awardID": "067976-2025-1",
            "title": "Lot 1 - NHS North-West GMS",
            "status": "active",
            "value": {
                "amount": 5175000000,
                "currency": "GBP"
            },
            "dateSigned": "2025-10-21T00:00:00+01:00"
        },
        {
            "id": "067976-2025-2",
            "awardID": "067976-2025-2",
            "title": "Lot 2 - NHS North-East and Yorkshire GMS",
            "status": "active",
            "value": {
                "amount": 5175000000,
                "currency": "GBP"
            },
            "dateSigned": "2025-10-21T00:00:00+01:00"
        },
        {
            "id": "067976-2025-3",
            "awardID": "067976-2025-3",
            "title": "Lot 3 NHS Central and South GMS",
            "status": "active",
            "value": {
                "amount": 5175000000,
                "currency": "GBP"
            },
            "dateSigned": "2025-10-21T00:00:00+01:00"
        },
        {
            "id": "067976-2025-4",
            "awardID": "067976-2025-4",
            "title": "Lot 4 NHS East GMS",
            "status": "active",
            "value": {
                "amount": 5175000000,
                "currency": "GBP"
            },
            "dateSigned": "2025-10-21T00:00:00+01:00"
        },
        {
            "id": "067976-2025-5",
            "awardID": "067976-2025-5",
            "title": "Lot 5 NHS South-West GMS",
            "status": "active",
            "value": {
                "amount": 5175000000,
                "currency": "GBP"
            },
            "dateSigned": "2025-10-21T00:00:00+01:00"
        },
        {
            "id": "067976-2025-6",
            "awardID": "067976-2025-6",
            "title": "Lot 6 NHS North Thames GMS",
            "status": "active",
            "value": {
                "amount": 5175000000,
                "currency": "GBP"
            },
            "dateSigned": "2025-10-21T00:00:00+01:00"
        },
        {
            "id": "067976-2025-7",
            "awardID": "067976-2025-7",
            "title": "Lot 7 NHS South-East GMS",
            "status": "active",
            "value": {
                "amount": 5175000000,
                "currency": "GBP"
            },
            "dateSigned": "2025-10-21T00:00:00+01:00"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "1",
                "measure": "bids",
                "relatedLot": "1",
                "value": 3
            },
            {
                "id": "2",
                "measure": "bids",
                "relatedLot": "2",
                "value": 3
            },
            {
                "id": "3",
                "measure": "bids",
                "relatedLot": "3",
                "value": 3
            },
            {
                "id": "4",
                "measure": "bids",
                "relatedLot": "4",
                "value": 3
            },
            {
                "id": "5",
                "measure": "bids",
                "relatedLot": "5",
                "value": 3
            },
            {
                "id": "6",
                "measure": "bids",
                "relatedLot": "6",
                "value": 3
            },
            {
                "id": "7",
                "measure": "bids",
                "relatedLot": "7",
                "value": 3
            }
        ]
    }
}